Omega Healthcare Investors (NYSE:OHI) Issues FY 2026 Earnings Guidance

Omega Healthcare Investors (NYSE:OHIGet Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 3.150-3.250 for the period, compared to the consensus estimate of 2.460. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of brokerages have issued reports on OHI. BMO Capital Markets lowered Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 target price on the stock. in a research report on Friday, January 9th. Royal Bank Of Canada increased their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 6th. UBS Group lifted their target price on Omega Healthcare Investors from $50.00 to $51.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Citigroup reiterated a “buy” rating and set a $50.00 price target (up from $45.00) on shares of Omega Healthcare Investors in a research note on Wednesday, November 12th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $45.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.82.

Read Our Latest Research Report on Omega Healthcare Investors

Omega Healthcare Investors Stock Up 0.0%

Omega Healthcare Investors stock traded up $0.01 during midday trading on Wednesday, reaching $42.94. The company’s stock had a trading volume of 2,787,669 shares, compared to its average volume of 2,012,738. The company has a market cap of $12.69 billion, a P/E ratio of 23.99, a P/E/G ratio of 1.39 and a beta of 0.57. The company has a quick ratio of 7.11, a current ratio of 7.11 and a debt-to-equity ratio of 0.95. The business has a 50-day simple moving average of $44.43 and a 200-day simple moving average of $42.58. Omega Healthcare Investors has a fifty-two week low of $35.04 and a fifty-two week high of $46.36.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last released its quarterly earnings data on Wednesday, February 4th. The real estate investment trust reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.01. Omega Healthcare Investors had a return on equity of 10.72% and a net margin of 46.83%.Omega Healthcare Investors has set its FY 2026 guidance at 3.150-3.250 EPS. On average, research analysts expect that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Monday, February 9th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.2%. The ex-dividend date of this dividend is Monday, February 9th. Omega Healthcare Investors’s payout ratio is presently 149.72%.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CIO Vikas Gupta bought 11,500 shares of the stock in a transaction dated Thursday, November 6th. The shares were acquired at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the transaction, the executive owned 13,773 shares in the company, valued at approximately $591,825.81. The trade was a 505.94% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 1.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Omega Healthcare Investors

Hedge funds have recently added to or reduced their stakes in the company. Sivia Capital Partners LLC acquired a new position in shares of Omega Healthcare Investors during the 2nd quarter worth $257,000. Danske Bank A S purchased a new position in Omega Healthcare Investors in the third quarter valued at about $84,000. Smartleaf Asset Management LLC lifted its position in shares of Omega Healthcare Investors by 40.9% during the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 268 shares during the period. Boothbay Fund Management LLC purchased a new stake in shares of Omega Healthcare Investors during the 3rd quarter worth approximately $341,000. Finally, NorthRock Partners LLC increased its stake in Omega Healthcare Investors by 5.6% in the 3rd quarter. NorthRock Partners LLC now owns 6,170 shares of the real estate investment trust’s stock valued at $260,000 after purchasing an additional 326 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

See Also

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.